Howard Greenberg

2.6k total citations
63 papers, 2.1k citations indexed

About

Howard Greenberg is a scholar working on Pharmacology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Howard Greenberg has authored 63 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 13 papers in Pharmacology and 8 papers in Infectious Diseases. Recurrent topics in Howard Greenberg's work include Pharmacogenetics and Drug Metabolism (13 papers), Inflammatory mediators and NSAID effects (9 papers) and Statistical Methods in Clinical Trials (6 papers). Howard Greenberg is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Inflammatory mediators and NSAID effects (9 papers) and Statistical Methods in Clinical Trials (6 papers). Howard Greenberg collaborates with scholars based in United States, Canada and Belgium. Howard Greenberg's co-authors include Scott A. Waldman, Walter K. Kraft, Paul Deutsch, Lisa Gillen, Michael Hesney, Robert B. Case, Keith Gottesdiener, Çharles N. Bernstein, Julie A. Stone and Gregory A. Winchell and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Circulation Research.

In The Last Decade

Howard Greenberg

63 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Howard Greenberg United States 26 549 476 355 332 294 63 2.1k
Bernd Rosenkranz South Africa 32 545 1.0× 451 0.9× 396 1.1× 586 1.8× 328 1.1× 115 3.3k
David Czock Germany 23 435 0.8× 328 0.7× 236 0.7× 170 0.5× 377 1.3× 111 2.3k
Manuel Haschke Switzerland 29 372 0.7× 463 1.0× 395 1.1× 490 1.5× 278 0.9× 113 3.2k
Thaddeus H. Grasela United States 31 905 1.6× 363 0.8× 249 0.7× 223 0.7× 529 1.8× 100 2.6k
Seo Hyun Yoon South Korea 25 349 0.6× 482 1.0× 169 0.5× 319 1.0× 395 1.3× 104 2.1k
Martin Bergstrand Sweden 17 487 0.9× 315 0.7× 228 0.6× 235 0.7× 340 1.2× 38 2.5k
Richard L. Slaughter United States 27 440 0.8× 270 0.6× 173 0.5× 376 1.1× 190 0.6× 64 1.9k
Cees Neef Netherlands 32 476 0.9× 264 0.6× 344 1.0× 252 0.8× 380 1.3× 116 3.1k
Richard A. Robson New Zealand 29 330 0.6× 184 0.4× 513 1.4× 388 1.2× 489 1.7× 87 2.8k
Suodi Zhai China 32 608 1.1× 586 1.2× 490 1.4× 176 0.5× 497 1.7× 181 3.5k

Countries citing papers authored by Howard Greenberg

Since Specialization
Citations

This map shows the geographic impact of Howard Greenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Greenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Greenberg more than expected).

Fields of papers citing papers by Howard Greenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Greenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Greenberg. The network helps show where Howard Greenberg may publish in the future.

Co-authorship network of co-authors of Howard Greenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Howard Greenberg. A scholar is included among the top collaborators of Howard Greenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howard Greenberg. Howard Greenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Howard, et al.. (2017). Structured Risk Assessment for First-in-Human Studies. Therapeutic Innovation & Regulatory Science. 51(3). 288–297. 3 indexed citations
2.
Smith, William B., et al.. (2017). Hot Button Protocol and Operational Issues Between Sponsors and Sites in Clinical Pharmacology Studies: A Moderated Forum Session. Therapeutic Innovation & Regulatory Science. 51(3). 298–302. 1 indexed citations
3.
Ford, Lisa, et al.. (2017). Comprehensive review of visual defects reported with topiramate. Clinical ophthalmology. Volume 11. 983–992. 2 indexed citations
4.
Goldberg, Jeffrey L., et al.. (2016). Is uveitis associated with topiramate use? A cumulative review. Clinical ophthalmology. Volume 10. 1467–1470. 6 indexed citations
5.
6.
Tsunoda, Shirley M., Howard Greenberg, J. Christopher Gorski, et al.. (2013). Evaluation of partial area under the concentration time curve to estimate midazolam apparent oral clearance for cytochrome P450 3A phenotyping. Drug metabolism and drug interactions. 28(4). 217–223. 7 indexed citations
7.
Nguyen, Emily T., et al.. (2010). Assessment of oral midazolam limited sampling strategies to predict area under the concentration time curve (AUC) during cytochrome P450 (CYP) 3A baseline, inhibition and induction or activation. International Journal of Clinical Pharmacology and Therapeutics. 48(12). 847–853. 9 indexed citations
8.
Stoch, S. Aubrey, Cynthia Gargano, J L Valentine, et al.. (2010). Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant. Cancer Chemotherapy and Pharmacology. 67(6). 1313–1321. 13 indexed citations
9.
Jin, Bo, Sheila Breidinger, Steven D. Young, et al.. (2009). Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms. Clinical Pharmacology & Therapeutics. 85(6). 623–627. 76 indexed citations
10.
Bertino, Joseph, Howard Greenberg, & Michael D. Reed. (2007). American College of Clinical Pharmacology Position Statement on the Use of Microdosing in the Drug Development Process. The Journal of Clinical Pharmacology. 47(4). 418–422. 34 indexed citations
11.
Lai, Eseng, Inge De Lepeleire, Fang Liu, et al.. (2007). Pharmacokinetics, Pharmacodynamics, and Safety of a Prostaglandin D2 Receptor Antagonist. Clinical Pharmacology & Therapeutics. 83(6). 840–847. 41 indexed citations
12.
Greenberg, Howard, et al.. (2007). Human Pharmacokinetics and Interconversion of Enantiomers of MK‐0767, a Dual PPARα/γ Agonist. The Journal of Clinical Pharmacology. 47(3). 323–333. 7 indexed citations
13.
Patel, Tarun B., et al.. (2007). Transgenic avian-derived recombinant human interferon-a2b (AVI-005) in healthy subjects: an open-label, single-dose, controlled study. International Journal of Clinical Pharmacology and Therapeutics. 45(3). 161–168. 6 indexed citations
14.
Bergman, Arthur, Joanne Burke, Patrick Larson, et al.. (2006). Effects of Ezetimibe on Cyclosporine Pharmacokinetics in Healthy Subjects. The Journal of Clinical Pharmacology. 46(3). 321–327. 23 indexed citations
15.
Majumdar, Anup, Laura Howard, Michael R. Goldberg, et al.. (2006). Pharmacokinetics of Aprepitant After Single and Multiple Oral Doses in Healthy Volunteers. The Journal of Clinical Pharmacology. 46(3). 291–300. 84 indexed citations
16.
Grant, David, et al.. (2004). Crohn's Disease Recurrence in a Small Bowel Transplant. The American Journal of Gastroenterology. 99(1). 158–162. 15 indexed citations
17.
Wagner, John A., Walter K. Kraft, Joanne Burke, et al.. (2001). THE COX-2 INHIBITOR ETORICOXIB DID NOT ALTER THE ANTI-PLATELET EFFECTS OF LOW-DOSE ASPIRIN IN HEALTHY VOLUNTEERS.. Arthritis & Rheumatism. 44(9). 5 indexed citations
18.
Zannikos, Peter, Bradford K. Jensen, Bruno Boutouyrie, et al.. (2000). Pharmacokinetics and Safety of Single Intravenous Infusions of the Adenosine Agonist, AMP 579, in Patients with End‐Stage Renal Insufficiency. The Journal of Clinical Pharmacology. 40(7). 745–751. 3 indexed citations
19.
Ilnyckyj, Alexandra, Howard Greenberg, & C N Bernstein. (1997). Escherichia coli O157:H7 infection mimicking Crohn's disease. Gastroenterology. 112(3). 995–999. 32 indexed citations
20.
Pimentel, Mark, James B. Johnston, Donald R. Allan, Howard Greenberg, & Çharles N. Bernstein. (1997). Primary Adrenal Lymphoma Associated with Adrenal Insufficiency: A Distinct Clinical Entity. Leukemia & lymphoma. 24(3-4). 363–367. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernd Rosenkranz Breakdown of academic impact, for papers by David Czock Breakdown of academic impact, for papers by Manuel Haschke Breakdown of academic impact, for papers by Thaddeus H. Grasela Breakdown of academic impact, for papers by Seo Hyun Yoon Breakdown of academic impact, for papers by Martin Bergstrand Breakdown of academic impact, for papers by Richard L. Slaughter Breakdown of academic impact, for papers by Cees Neef Breakdown of academic impact, for papers by Richard A. Robson Breakdown of academic impact, for papers by Suodi Zhai
Rankless by CCL
2026